Characteristics Of Sars-Cov-2 Variants Of Concern B.1.1.7, B.1.351 Or P.1: Data From Seven Eu/Eea Countries, Weeks 38/2020 To 10/2021

Tjede Funk,Anastasia Pharris,Gianfranco Spiteri,Nick Bundle,Angeliki Melidou,Michael Carr,Gabriel Gonzalez,Alejandro Garcia-Leon,Fiona Crispie,Lois O'Connor,Niamh Murphy,Joël Mossong,Anne Vergison, Anke K Wienecke-Baldacchino,Tamir Abdelrahman,Flavia Riccardo,Paola Stefanelli,Angela Di Martino,Antonino Bella,Alessandra Lo Presti,Pedro Casaca,Joana Moreno,Vítor Borges,Joana Isidro,Rita Ferreira,João Paulo Gomes, Liidia Dotsenko, Heleene Suija, Jevgenia Epstein, Olga Sadikova, Hanna Sepp,Niina Ikonen,Carita Savolainen-Kopra,Soile Blomqvist,Teemu Möttönen,Otto Helve, Joana Gomes-Dias,Cornelia Adlhoch

EUROSURVEILLANCE（2021）

引用 274|浏览12

暂无评分

摘要

We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).

查看译文

关键词

COVID-19,Europe,SARS-CoV-2,surveillance,variants of concern

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要